155 related articles for article (PubMed ID: 35644724)
1. Skin autofluorescence corresponds to microvascular reactivity in diabetes mellitus.
Škrha J; Horová E; Šoupal J; Valeriánová A; Malík J; Prázný M; Zima T; Kalousová M; Škrha J
J Diabetes Complications; 2022 Jul; 36(7):108206. PubMed ID: 35644724
[TBL] [Abstract][Full Text] [Related]
2. Advanced glycation end products, measured in skin, vs. HbA1c in children with type 1 diabetes mellitus.
Banser A; Naafs JC; Hoorweg-Nijman JJ; van de Garde EM; van der Vorst MM
Pediatr Diabetes; 2016 Sep; 17(6):426-32. PubMed ID: 26332801
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of skin autofluorescence as a surrogate of advanced glycation end products accumulation in children and adolescents with normal haemoglobin A1c values.
Jankowska M; Bobeff K; Baranowska-Jaźwiecka A; Mianowska M; Lubnauer A; Michalak A; Młynarski W; Szadkowska A; Mianowska B
Pediatr Endocrinol Diabetes Metab; 2020; 26(1):1-9. PubMed ID: 32418416
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Skin Autofluorescence and Its Association with Glycated Hemoglobin, Cardiovascular Risk Markers, and Concomitant Chronic Diseases in Children with Type 1 Diabetes.
Jankowska M; Szadkowska A; Pietrzak I; Chrzanowski J; Sołek J; Fendler W; Mianowska B
Nutrients; 2024 Jun; 16(12):. PubMed ID: 38931293
[TBL] [Abstract][Full Text] [Related]
5. Autofluorescence of Skin Advanced Glycation End Products: Marker of Metabolic Memory in Elderly Population.
Rajaobelina K; Cougnard-Gregoire A; Delcourt C; Gin H; Barberger-Gateau P; Rigalleau V
J Gerontol A Biol Sci Med Sci; 2015 Jul; 70(7):841-6. PubMed ID: 25589479
[TBL] [Abstract][Full Text] [Related]
6. Progression of skin autofluorescence of AGEs over 4 years in patients with type 1 diabetes.
Rajaobelina K; Helmer C; Vélayoudom-Céphise FL; Nov S; Farges B; Pupier E; Blanco L; Hugo M; Gin H; Rigalleau V
Diabetes Metab Res Rev; 2017 Oct; 33(7):. PubMed ID: 28719154
[TBL] [Abstract][Full Text] [Related]
7. Relationship between peripheral diabetic neuropathy and microvascular reactivity in patients with type 1 and type 2 diabetes mellitus -- neuropathy and microcirculation in diabetes.
Kasalová Z; Prázný M; Skrha J
Exp Clin Endocrinol Diabetes; 2006 Feb; 114(2):52-7. PubMed ID: 16570233
[TBL] [Abstract][Full Text] [Related]
8. Advanced glycation end products, measured as skin autofluorescence, during normal pregnancy and pregnancy complicated by diabetes mellitus.
de Ranitz-Greven WL; Kaasenbrood L; Poucki WK; Hamerling J; Bos DC; Visser GH; Biesma DH; Beulens JW; de Valk HW
Diabetes Technol Ther; 2012 Dec; 14(12):1134-9. PubMed ID: 23113747
[TBL] [Abstract][Full Text] [Related]
9. Skin autofluorescence Is associated With low bone mineral density in type 2 diabetic patients.
Yavuz DG; Apaydin T
J Clin Densitom; 2022; 25(3):373-379. PubMed ID: 34933784
[TBL] [Abstract][Full Text] [Related]
10. Skin autofluorescence is associated with past glycaemic control and complications in type 1 diabetes mellitus.
Genevieve M; Vivot A; Gonzalez C; Raffaitin C; Barberger-Gateau P; Gin H; Rigalleau V
Diabetes Metab; 2013 Sep; 39(4):349-54. PubMed ID: 23643347
[TBL] [Abstract][Full Text] [Related]
11. In diabetic Charcot neuroarthropathy impaired microvascular function is related to long lasting metabolic control and low grade inflammatory process.
Araszkiewicz A; Soska J; Borucka K; Olszewska M; Niedzwiecki P; Wierusz-Wysocka B; Zozulinska-Ziolkiewicz D
Microvasc Res; 2015 Sep; 101():143-7. PubMed ID: 26239695
[TBL] [Abstract][Full Text] [Related]
12. Skin autofluorescence of Advanced Glycation End-products and mortality in older adults: The roles of chronic kidney disease and diabetes.
Majchrzak C; Cougnard-Gregoire A; Le-Goff M; Féart C; Delcourt C; Reydit M; Helmer C; Rigalleau V
Nutr Metab Cardiovasc Dis; 2022 Nov; 32(11):2526-2533. PubMed ID: 36064683
[TBL] [Abstract][Full Text] [Related]
13. Increased skin autofluorescence of children and adolescents with type 1 diabetes despite a well-controlled HbA1c: results from a cohort study.
van der Heyden JC; Birnie E; Mul D; Bovenberg S; Veeze HJ; Aanstoot HJ
BMC Endocr Disord; 2016 Sep; 16(1):49. PubMed ID: 27613110
[TBL] [Abstract][Full Text] [Related]
14. Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes.
Tan KC; Shiu SW; Chow WS; Leng L; Bucala R; Betteridge DJ
Diabetologia; 2006 Nov; 49(11):2756-62. PubMed ID: 16969649
[TBL] [Abstract][Full Text] [Related]
15. Relationship between cardiac tissue glycation and skin autofluorescence in patients with coronary artery disease.
Hofmann B; Jacobs K; Navarrete Santos A; Wienke A; Silber RE; Simm A
Diabetes Metab; 2015 Nov; 41(5):410-5. PubMed ID: 25553578
[TBL] [Abstract][Full Text] [Related]
16. Morbid obesity leads to increased skin autofluorescence independent of metabolic syndrome components.
Apaydın T; Yavuz DG
Turk J Med Sci; 2022 Aug; 52(4):1085-1092. PubMed ID: 36326402
[TBL] [Abstract][Full Text] [Related]
17. Non-invasive measures of tissue autofluorescence are increased in Type 1 diabetes complications and correlate with a non-invasive measure of vascular dysfunction.
Januszewski AS; Sachithanandan N; Karschimkus C; O'Neal DN; Yeung CK; Alkatib N; Jenkins AJ
Diabet Med; 2012 Jun; 29(6):726-33. PubMed ID: 22211881
[TBL] [Abstract][Full Text] [Related]
18. The Bright Side of Skin Autofluorescence Determination in Children and Adolescents with Newly Diagnosed Type 1 Diabetes Mellitus: A Potential Predictor of Remission?
Podolakova K; Barak L; Jancova E; Stanik J; Sebekova K; Podracka L
Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231246
[TBL] [Abstract][Full Text] [Related]
19. The relationship between sudomotor function and skin microvascular reactivity in individuals with type 1 diabetes of long duration.
Gandecka A; Araszkiewicz A; Piłaciński S; Wierusz-Wysocka B; Zozulińska-Ziółkiewicz D
Microvasc Res; 2018 Nov; 120():84-89. PubMed ID: 30044961
[TBL] [Abstract][Full Text] [Related]
20. Skin autofluorescence is associated with severity of vascular complications in Japanese patients with Type 2 diabetes.
Tanaka K; Tani Y; Asai J; Nemoto F; Kusano Y; Suzuki H; Hayashi Y; Asahi K; Nakayama M; Miyata T; Watanabe T
Diabet Med; 2012 Apr; 29(4):492-500. PubMed ID: 21916970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
